Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
1.150
+0.030 (2.68%)
At close: Oct 22, 2024, 4:00 PM
1.151
+0.001 (0.04%)
After-hours: Oct 22, 2024, 5:00 PM EDT
Lyell Immunopharma Market Cap
Lyell Immunopharma has a market cap or net worth of $294.40 million as of October 23, 2024. Its market cap has decreased by -15.62% in one year.
Market Cap
294.40M
Enterprise Value
-136.49M
1-Year Change
-15.62%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $294.40M, a decrease of -92.87%. That is a compound annual growth rate of -54.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2024 | 294.40M | -39.75% |
| Dec 29, 2023 | 488.60M | -43.53% |
| Dec 30, 2022 | 865.20M | -53.51% |
| Dec 31, 2021 | 1.86B | -54.91% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atea Pharmaceuticals | 300.54M |
| Spok Holdings | 299.91M |
| Rezolute | 295.86M |
| AngioDynamics | 295.41M |
| Sanara MedTech | 295.39M |
| Nkarta | 293.52M |
| Immutep | 291.63M |
| Genfit | 290.30M |